FOS and breast carcinoma: In conclusion, our data have shown that DACH1 inhibited breast cancer metastasis by down-regulating the expression of MMP9. In terms of mechanism, DACH1 interacted with p65 and c-Jun at the NF-κB and AP-1 binding sites respectively.